Constipation Clinical Trial
Official title:
Improvement of Functional Constipation With Kiwifruit Intake in a Mediterranean Patient Population: Open Non-controlled and Non-randomized Longitudinal Study
Constipation is a symptom suffered by a large number of people, due to multifactorial
causes. Some studies have proven that modifying lifestyle reduces the risk of constipation,
with high-fibre diets being less prone to constipation. Kiwifruit consumption, improves
functional constipation and some studies consistently report an increase in the frequency
and ease of defecation, stool volume and softness.
Although literature suggests kiwifruit consumption improves constipation symptoms, no
studies have been carried out in adults and in Mediterranean patient populations,
characteristic for its differential nutritional habits. The aim of the present study was to
test the effect of kiwifruit consumption on functional constipation in a Spanish adult
population.
Worldwide general population prevalence of constipation ranges from 0.7% to 79% (median
16%). Some factors associated with constipation are sex, with higher prevalence in females
(especially during pregnancy, and age; in general it becomes gradually more prevalent after
the 70 years of age, in women the increase is considerable from a young age (18-23 years
old) to middle age (45-50 years old).
Constipation is characterized by difficult or infrequent deposition, often accompanied by
excessive straining during bowel movement or sensation of incomplete evacuation. In most
cases, there is no underlying organic cause, and constipation is labelled as chronic
idiopathic constipation and as a functional digestive disorder. The Rome III criteria is a
useful tool for the diagnosis of constipation that highlights the chronic nature of the
disorder and the importance of symptoms beyond the infrequency of bowel movements.
Understanding its causes, prevention, and treatment will help most people find constipation
relief. An individual's medical history is very important in determining a constipation
diagnosis. Primary healthcare professionals should enquire about dietary habits and
lifestyle, pharmacological and toxic habits, complementary and alternative medicine,
physiological bowel habits, use of laxatives and past disease history
Aims:
To test the effect of kiwifruit consumption on functional constipation in a Spanish adult
population
Methods:
Design :Open non-controlled and non-randomized longitudinal study, of the effect of
kiwifruit consumption in adult patients with diagnosed constipation
Setting: The study was conducted in five primary healthcare centres in Barcelona, Catalonia,
Spain.
Period Study: Between April and August 2013
Population: Fifteen participating Primary Care Professionals selected patients from the
electronic medical records (e-HCAP) following inclusion and exclusion criteria. Each
professional could include a maximum of 4 patients. Forty-six subjects were selected for the
study
Sample size: It was calculated to detect a change in the proportion of individuals with 3 or
more defecations per week from 56% to 86% (evolution from an average of 3.2 to 4.4 -stable
Standard Deviation (SD) of 1.3- in a normal distribution). Assuming a bilateral contrast for
paired data, with a significance level of 0.05 and power of 0.8, a sample of 44 individuals
was required (covering a 10% of dropout rate).
Intervention: The duration of the study was five weeks. During the first two weeks no
kiwifruit patients were asked to follow their normal diet. The next three weeks they were
asked to consume three Zespri green kiwifruits (Actinidia deliciosa var Hayward) per day,
one at each main meal (breakfast, lunch and dinner). Throughout the five-week study period
the patient had to continue their normal eating habits and exercise regime.
Tools and instructions: Primary Care Professionals asked patients to participate in the
study and explained it to them. Patients who voluntarily agreed to participate signed the
informed consent, accepting all study procedures. Each participant in the study attended
three consultations: the first one before starting the study, the second one after two weeks
and the third one after five weeks.
To collect the information patients used a questionnaire designed for this purpose. His/her
Primary Care Professional provided instructions on the recording of faecal characteristics.
The French original version of the diary was translated into Spanish and Catalan. Patients
chose their own language to respond. Professionals collected data from diaries in a Google
Docs form.
Patients were supplied kiwifruits in a heterogeneous manner. Some patients in the study
bought the prescribed product. In other cases it was the professional who provided the
kiwifruits. In one of the Primary Care Centres, the neighbourhood shopkeeper was the
responsible for delivering the kiwifruits to the patients. Patients who bought their own
Zespri kiwifruit were refunded.
Statistical analysis: Demographics for patients were summarized calculating medians
[InterQuartile Range (IQR)] for continuous variables and proportions for categorical
variables. Categorical variables were compared from baseline (second week) to last week
using the Bhapkar test. For some analyses, Facility and Volume categorical variables were
treated as continuous in order to provide results easy to interpret and taking into account
individuals' correlations; in these cases, one unit of gain should be interpreted as an
improvement in one response category. Functional data methodology was used for some
graphical representations. Stacked barplots over time will be presented for categorical
variables. To analyse week changes in daily variables Generalized Estimating Equation (GEE)
models were adjusted (treating variables as continuous).
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |